Longeveron (LGVN) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $1.39, -7.33% vs the prior close of $1.50.
- Volume 65.31K shares, 0.6x its 50-day average (light).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
LGVN slides 7.3% to $1.39, a 52-week low, 5 down days in a row. Closed at $1.39, -7.33% vs the prior close of $1.50. Day range $1.36–$1.49, opened at $1.47.
LGVN daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — LGVN slides 7.3% to $1.39, a 52-week low, 5 down days in a row
- Closed at $1.39, -7.33% vs the prior close of $1.50. Day range $1.36–$1.49, opened at $1.47.
- Volume was 65.31K shares, 0.6x its 50-day average of 117.91K — lighter than usual.
- Price is -72.8% vs its 50-day average ($5.11) and -79.7% vs its 200-day average ($6.85).
- 52-week range $1.36–$12.30; today's close sits at 0% of that range, 88.7% below the 52-week high.
- That makes 5 straight losses.
Oct 15, 2026 — LGVN slides 13.3% to $1.50, a 52-week low, 4 down days in a row
- Closed at $1.50, -13.29% vs the prior close of $1.73. Day range $1.37–$1.71, opened at $1.68.
- Volume was 150.40K shares, 1.3x its 50-day average of 115.36K.
- Price is -71.3% vs its 50-day average ($5.23) and -78.1% vs its 200-day average ($6.86).
- 52-week range $1.37–$12.30; today's close sits at 1% of that range, 87.8% below the 52-week high.
- That makes 4 straight losses.
Oct 14, 2026 — LGVN slides 19.5% to $1.73, a 52-week low, 3 down days in a row
- Closed at $1.73, -19.53% vs the prior close of $2.15. Day range $1.69–$2.11, opened at $2.11.
- Volume was 158.60K shares, 1.4x its 50-day average of 113.75K.
- Price is -67.7% vs its 50-day average ($5.35) and -74.9% vs its 200-day average ($6.88).
- 52-week range $1.69–$12.30; today's close sits at 0% of that range, 85.9% below the 52-week high.
- That makes 3 straight losses.
- SEC filings that day: 8-K.
Oct 13, 2026 — LGVN slides 12.2% to $2.15, a 52-week low
- Closed at $2.15, -12.24% vs the prior close of $2.45. Day range $2.14–$2.44, opened at $2.42.
- Volume was 60.50K shares, 0.5x its 50-day average of 113.13K — lighter than usual.
- Price is -60.6% vs its 50-day average ($5.46) and -68.8% vs its 200-day average ($6.90).
- 52-week range $2.14–$12.30; today's close sits at 0% of that range, 82.5% below the 52-week high.
Oct 12, 2026 — LGVN dips 1.2% to $2.45
- Closed at $2.45, -1.21% vs the prior close of $2.48. Day range $2.42–$2.55, opened at $2.49.
- Volume was 34.70K shares, 0.3x its 50-day average of 113.74K — lighter than usual.
- Price is -56.0% vs its 50-day average ($5.57) and -64.6% vs its 200-day average ($6.92).
- 52-week range $2.30–$12.30; today's close sits at 2% of that range, 80.1% below the 52-week high.
Oct 9, 2026 — LGVN jumps 4.6% to $2.48
- Closed at $2.48, +4.64% vs the prior close of $2.37. Day range $2.34–$2.60, opened at $2.40.
- Volume was 58.40K shares, 0.5x its 50-day average of 113.54K — lighter than usual.
- Price is -56.2% vs its 50-day average ($5.66) and -64.2% vs its 200-day average ($6.93).
- 52-week range $2.30–$12.30; today's close sits at 2% of that range, 79.8% below the 52-week high.
Oct 8, 2026 — LGVN dips 2.9% to $2.37
- Closed at $2.37, -2.87% vs the prior close of $2.44. Day range $2.32–$2.57, opened at $2.45.
- Volume was 77.20K shares, 0.7x its 50-day average of 112.34K.
- Price is -58.7% vs its 50-day average ($5.74) and -65.9% vs its 200-day average ($6.95).
- 52-week range $2.30–$12.30; today's close sits at 1% of that range, 80.7% below the 52-week high.
Oct 7, 2026 — LGVN jumps 3.8% to $2.44
- Closed at $2.44, +3.83% vs the prior close of $2.35. Day range $2.33–$2.48, opened at $2.33.
- Volume was 58.10K shares, 0.5x its 50-day average of 111.32K — lighter than usual.
- Price is -58.0% vs its 50-day average ($5.81) and -65.0% vs its 200-day average ($6.96).
- 52-week range $2.30–$12.30; today's close sits at 1% of that range, 80.2% below the 52-week high.
Oct 6, 2026 — LGVN slides 6.4% to $2.35, a 52-week low, 5 down days in a row
- Closed at $2.35, -6.37% vs the prior close of $2.51. Day range $2.34–$2.50, opened at $2.50.
- Volume was 83.60K shares, 0.8x its 50-day average of 110.00K.
- Price is -60.1% vs its 50-day average ($5.89) and -66.3% vs its 200-day average ($6.98).
- 52-week range $2.30–$12.30; today's close sits at 0% of that range, 80.9% below the 52-week high.
- That makes 5 straight losses.
Oct 5, 2026 — LGVN dips 2.7% to $2.51, 4 down days in a row
- Closed at $2.51, -2.71% vs the prior close of $2.58. Day range $2.51–$2.69, opened at $2.59.
- Volume was 44.20K shares, 0.4x its 50-day average of 109.44K — lighter than usual.
- Price is -57.9% vs its 50-day average ($5.96) and -64.1% vs its 200-day average ($7.00).
- 52-week range $2.30–$12.30; today's close sits at 2% of that range, 79.6% below the 52-week high.
- That makes 4 straight losses.
Oct 2, 2026 — LGVN dips 0.4% to $2.58, 3 down days in a row
- Closed at $2.58, -0.39% vs the prior close of $2.59. Day range $2.54–$2.67, opened at $2.56.
- Volume was 20.80K shares, 0.2x its 50-day average of 109.24K — lighter than usual.
- Price is -57.2% vs its 50-day average ($6.03) and -63.2% vs its 200-day average ($7.01).
- 52-week range $2.30–$12.30; today's close sits at 3% of that range, 79.0% below the 52-week high.
- That makes 3 straight losses.
LGVN latest news & SEC filings
Every SEC filing by or about LGVN in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 14, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
Oct 5, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Jhaveri Nirav S. had withheld for taxes 742 shares at $2.59 (≈$1.92K) on Oct 1, 2026; now holds 29,258
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 5, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Willard Stephen H had withheld for taxes 1,987 shares at $2.59 (≈$5.15K) on Oct 1, 2026; now holds 74,916
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 5, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Agafonova Nataliya had withheld for taxes 2,913 shares at $2.59 (≈$7.54K) on Oct 1, 2026; now holds 68,778
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 5, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Lehr Paul T had withheld for taxes 2,253 shares at $2.59 (≈$5.84K) on Oct 1, 2026; now holds 83,889
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 5, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Blass Devin had withheld for taxes 2,520 shares at $2.59 (≈$6.53K) on Oct 1, 2026; now holds 68,653
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 23, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Sep 14, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Sep 10, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 25, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 24, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.03 — Amended its charter or bylaws / changed fiscal year.
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Aug 19, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
Aug 13, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 12, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Aug 12, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $287.00K (prior year $316.00K) (-9.2% vs Jun 30, 2025)
- Net income: -$6.07M (prior year -$5.03M) (loss widened vs Jun 30, 2025)
- Diluted EPS: -$0.19 (prior year -$0.33) (loss narrowed vs Jun 30, 2025)
Things to know before you trade LGVN
- Last results release: Aug 12, 2026 (8-K Item 2.02). Previous ones: May 13, 2026, Nov 4, 2025, Aug 13, 2025. Based on that rhythm, the next report is likely around Nov 11, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 6.07% (largest 19.5%). That is a volatile stock.
- Liquidity: about 89.07K shares (≈$123.80K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $1.39 vs a range of $1.36–$12.30 (0% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: 1:10 on Aug 27, 2026
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
- Latest filings: 8-K Oct 14, 2026; 8-K Sep 23, 2026; 8-K Sep 14, 2026.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
LGVN market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 1.47 | 1.49 | 1.36 | 1.39 | 65.31K |
| Oct 15, 2026 | 1.68 | 1.71 | 1.37 | 1.50 | 150.40K |
| Oct 14, 2026 | 2.11 | 2.11 | 1.69 | 1.73 | 158.60K |
| Oct 13, 2026 | 2.42 | 2.44 | 2.14 | 2.15 | 60.50K |
| Oct 12, 2026 | 2.49 | 2.55 | 2.42 | 2.45 | 34.70K |
| Oct 9, 2026 | 2.40 | 2.60 | 2.34 | 2.48 | 58.40K |
| Oct 8, 2026 | 2.45 | 2.57 | 2.32 | 2.37 | 77.20K |
| Oct 7, 2026 | 2.33 | 2.48 | 2.33 | 2.44 | 58.10K |
| Oct 6, 2026 | 2.50 | 2.50 | 2.34 | 2.35 | 83.60K |
| Oct 5, 2026 | 2.59 | 2.69 | 2.51 | 2.51 | 44.20K |
| Oct 2, 2026 | 2.56 | 2.67 | 2.54 | 2.58 | 20.80K |
| Oct 1, 2026 | 2.72 | 2.74 | 2.52 | 2.59 | 72.90K |
| Sep 30, 2026 | 2.73 | 2.80 | 2.61 | 2.69 | 55.00K |
| Sep 29, 2026 | 2.68 | 2.74 | 2.60 | 2.72 | 55.20K |
| Sep 28, 2026 | 2.79 | 2.79 | 2.62 | 2.63 | 97.00K |
| Sep 25, 2026 | 2.89 | 2.95 | 2.76 | 2.81 | 50.10K |
| Sep 24, 2026 | 2.54 | 2.97 | 2.50 | 2.91 | 172.00K |
| Sep 23, 2026 | 2.68 | 2.76 | 2.53 | 2.60 | 62.30K |
| Sep 22, 2026 | 2.47 | 2.83 | 2.32 | 2.72 | 233.50K |
| Sep 21, 2026 | 2.49 | 2.54 | 2.33 | 2.45 | 171.50K |
About Longeveron
Longeveron (LGVN) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in MIAMI, FL. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1721484.
LGVN board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Deborah Ascheim | Director | Aug 21, 2026 |
| Leah Rush Cann | Director | Aug 21, 2026 |
| Arjun Jj Desai | Director | Aug 21, 2026 |
| Roger Joseph Hajjar | Director | Aug 21, 2026 |
| Joshua Hare | Chief Scientific Officer | Aug 21, 2026 |
| George A. Jr. Paletta | Director | Aug 21, 2026 |
| Rock Soffer | Director | Aug 21, 2026 |
| Ursula Ungaro | Director | Aug 21, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Nataliya Agafonova | Chief Medical Officer | Aug 21, 2026 |
| Devin Blass | CTO & SVP of CMC | Aug 21, 2026 |
| Joshua Hare | Chief Scientific Officer | Aug 21, 2026 |
| Nirav S. Jhaveri | Chief Financial Officer | Aug 25, 2026 |
| Paul T Lehr | General Counsel, Secretary | Aug 21, 2026 |
| Lisa Locklear | Chief Financial Officer | Jul 6, 2026 |
| James Nathaniel Powell | Chief Executive Officer | Jan 6, 2026 |
| Marie Washburn | Chief Financial Officer | Jul 21, 2026 |
| Stephen H Willard | Chief Executive Officer | Jul 6, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| No open-market insider buys or sales reported in the last 12 months. | ||||
LGVN financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $1.20M | $-22.70M | -1.29 | $-18.64M |
| Dec 31, 2024 | $2.39M | $-15.97M | -2.62 | $-13.87M |
| Dec 31, 2023 | $709.00K | $-21.41M | -10.22 | $-19.00M |
| Dec 31, 2022 | — | $-18.84M | -0.90 | $-13.97M |
| Dec 31, 2021 | — | $-17.05M | -0.90 | $-9.64M |
Latest balance sheet: total assets $15.49M, total liabilities $5.08M, cash $10.08M (as of Jun 30, 2026).
LGVN earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 12, 2026 | 8-K Item 2.02 (results) | $7.47 |
| May 13, 2026 | 8-K Item 2.02 (results) | $7.55 |
| Nov 4, 2025 | 8-K Item 2.02 (results) | $8.00 |
| Aug 13, 2025 | 8-K Item 2.02 (results) | $8.60 |
| May 8, 2025 | 8-K Item 2.02 (results) | $14.90 |
| Feb 28, 2025 | 8-K Item 2.02 (results) | $15.20 |
| Nov 12, 2024 | 8-K Item 2.02 (results) | $23.00 |
| Aug 14, 2024 | 8-K Item 2.02 (results) | — |
| May 12, 2023 | 8-K Item 2.02 (results) | — |
| Mar 10, 2023 | 8-K Item 2.02 (results) | — |
| Nov 14, 2022 | 8-K Item 2.02 (results) | — |
| Aug 12, 2022 | 8-K Item 2.02 (results) | — |
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Novo Nordisk A S (NVO)Regeneron Pharmaceuticals (REGN)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on LGVN
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.